Thursday, June 30, 2016

Medical Documentation Needed for Mobility Assistive Equipment Coverage

If your mobility assistive equipment (Cane, crutches, walkers, wheelchairs, etc.)  Orders/prescriptions are being returned due to incomplete information. This information is for right for you.

This article is solely an educational guide to improve compliance with documentation requirements for the face-to-face examination that occurs prior to the physician or treating practitioner ordering a mobility assistive equipment (MAE) for their patients.

The prescription or justification must clearly document;

Ø The patient’s functional status with attention to conditions affecting the beneficiary’s mobility and their ability to perform activities of daily living within the home. Mobility related diagnosis are needed to justify the medical necessity of the MAE.

Ø The beneficiary has a mobility limitation that significantly impairs his/her ability to participate in one or more mobility-related activities of daily living (MRADL) in the home. The MRADLs to be considered are toileting, feeding, dressing, grooming, and bathing performed in customary locations in the home.

A mobility limitation is one that:

ü Prevents the beneficiary from accomplishing the MRADL entirely, or,

ü Places the beneficiary at reasonably determined heightened risk of morbidity or mortality secondary to the attempts to perform an MRADL; or,

ü Prevents the beneficiary from completing the MRADL within a reasonable time frame;

Ø The beneficiary is able to safely use the MAE.

Ø The functional mobility deficit can be sufficiently resolved by using a MAE.


Accurate and complete documentation regarding the face-to-face examination is extremely important to ensure the patient receives the appropriate MAE.

                                                                             Source: Centers for Medicare and Medicaid Services

Saturday, March 26, 2016

Six Quality Key Dimensions


Medidas HEDIS® COA-M vs MRP


Las sub-medidas COA-M (Revisión de medicamentos en el adulto) y MRP (reconciliación de medicamentos luego de un alta) pueden causar confusión ya que tienen algunas semejanzas.


COA-M
Revisión de Medicamentos en el adulto

COA-M incluye a afiliados de 66 años de edad o más que se le realizó una revisión de medicamentos durante el año de la medida.

Documentación necesaria


Evidencia en el expediente para el año de la medida.

Requiere un listado de medicamentos y una revisión de todos los medicamentos en uso por el paciente en el año de la medida.

La revisión puede ser llevada a cabo por el médico o el farmacéutico.

Una nota que indique que el paciente no toma ningún medicamento cumple con la medida.

El listado de medicamentos presente en el expediente puede incluir medicamentos OTC, vitaminas, hierbas y suplementos.

La firma del proveedor evidencia que los medicamentos fueron revisados.

Datos importantes

Ø  No se requiere una visita cara a cara para realizar la revisión.

Ø  Documentación dirigida a efectos secundarios solamente no es válida.

MRP
Reconciliación de medicamentos luego de un alta

MRP para cumplir con esta medida debe realizarse una reconciliación de medicamentos dentro de los primeros 30 dias de que el paciente mayor de 66 años haya sido dado de alta luego de una hospitalización. Esta medida busca que los médicos primarios tengan conocimiento de los medicamentos nuevos y cambios en medicamentos que puedan tener sus pacientes luego de un alta, de esa manera estos pueden hacer ajustes y garantizar una calidad de cuidado óptima.

Documentación necesaria
Evidencia en el expediente 30 días a partir de la fecha de alta.
Requiere evidencia comparativa de los medicamentos del alta con los medicamentos actuales del paciente. No se requiere un listado oficial, pero si requiere documentación que evidencie que ambos listados fueron comparados. La mejor evidencia es colocar una copia del resumen de alta (discharge summary) en el expediente y realizar la reconciliación a base de la información provista.
La revisión puede ser llevada a cabo por el médico, farmacéutico o enfermero registrado.


Documentación que indique que no se ordenaron medicamentos en el momento del alta cumple con la medida.
Datos importantes
Ø  No se requiere una visita cara a cara para realizar la revisión.
Ø  No puede utilizar record de hospitalización para validar la medida.
Ø  Un “discharge summary” (resumen de alta) solo en el expediente no es suficiente evidencia, debe estar claro que se realizó la reconciliación de los medicamentos luego del alta.
HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA). http://www.ncqa.org/HEDISQualityMeasurement/HEDISMeasures.aspx#sthash.Pqw4ZdnI.dpuf

Monday, March 21, 2016

How much do you know about the HEDIS® measures?


The Healthcare Effectiveness Data and Information Set (HEDIS) is one of the most widely used sets of health care performance measure in the United States. The term “HEDIS” originated in the late 1980s as the product of a group of forward-thinking employers and quality experts, and was entrusted to NCQA in the early 1990s. The NCQA measurement development process has expanded the size and scope of HEDIS to include measures for physicians, PPOs and other organizations. [1]

Measure – Care for older adults (COA) – Pain

To comply with this measure a pain assessment on adults older than 66 years old during the measurement year must be present on the clinical record.[2]

To clarify the HEDIS measure specifications the NCQA mentioned the following;

Necessary Documentation
Clinical documentation must include evidence of the pain assessment with a valid date of service. (The pain assessment can be either positive or negative)

Important Information
·         A specific number of evaluated body system is not required.
·         Documentation of a positive or negative pain assessment is acceptable.
·         Only one body system pain assessment evaluation is needed for compliance.

Don’t
·         Pain assessment documentation associated to an acute event of a single body system is not valid for compliance. (Ex, wisdom tooth pain, chest pain, back pain, pain due to trauma)
·         A clinical note for pain treatment only is not valid for compliance.





[1] HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA). http://www.ncqa.org/HEDISQualityMeasurement/HEDISMeasures.aspx#sthash.Pqw4ZdnI.dpuf
[2] HEDIS 2015: Technical Specifications for Health Plans Volume 2

Wednesday, March 16, 2016

¿Conoces las medidas HEDIS®?


El Healthcare Effectiveness Data and Information Set (HEDIS por sus siglas en inglés) es una de las herramientas que mide el desempeño en los servicios de salud  más utilizada en los Estados Unidos. El término “HEDIS” fue originado en los 80s por un grupo de empleados emprendedores y expertos en calidad, el mismo fue introducido al NCQA (National Committee of Quality Assurance por sus siglas en ingles) en los 90s. Durante el proceso de desarrollo de las medidas el NCQA ha expandido su tamaño y envergadura para incluir medidas para médicos,  organizaciones proveedoras de servicios de salud y otros proveedores.[1]

Iremos discutiendo cada una de las métricas HEDIS semanalmente. Comencemos con:


Métrica - Care for Older Adults (COA) - Pain     

La métrica de cuidado para el adulto-viejo (COA por sus siglas en ingles) en su medida de dolor, busca el porcentaje de adultos de 66 años o más al cual se le realizó un estimado de dolor durante el año de la medida.[2]

Para clarificar esta sub-medida el NCQA abarcó en las especificaciones de HEDIS las formas para validar la misma;

1.     Documentación necesaria
La documentación en el expediente clínico debe incluir evidencia de un estimado de dolor (el hallazgo puede ser positivo o negativo para dolor) y la fecha en que se realizó.

2.     Datos importantes:
• No es requerido un número específico de evaluación por sistemas para cumplir con el estimado de dolor.

• La documentación de un estimado de dolor ya sea positivo o negativo es aceptable.

• Solo se requiere la evaluación de un sistema de dolor para estar en cumplimiento.

No esta aceptado:

• Documentación de estimado de dolor asociado a un evento agudo de un solo sistema (ej. Dolor de muelas, dolor de oído, dolor de pecho, dolor de espalda, dolor por un trauma localizado); aunque utilice una herramienta estandarizada.

• Una nota de manejo de dolor o tratamiento para el dolor solo no valida la medida.

• Estimado de dolor de pecho solo no cumple con la medida.



[1]HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA). http://www.ncqa.org/HEDISQualityMeasurement/HEDISMeasures.aspx#sthash.Pqw4ZdnI.dpuf
[2] HEDIS 2015: Technical Specifications for Health Plans Volume 2

Thursday, December 17, 2015

Take the Necessary Steps toward Value-Based Care

Take the Necessary Steps toward Value-Based Care
As part of Medicare’s efforts to improve the quality and efficiency of medical care, the Physician Feedback/Value-Based Payment Modifier Program provides comparative performance information to physicians and medical practice groups. By providing meaningful and actionable information for doctors to apply towards quality improvement, CMS is shifting towards a model of physician reimbursement that rewards value rather than volume. Using workflow analysis and other proven methods, QIN-QIOs will help providers identify and close gaps in care coordination, improve efficiency and quality, and meet or exceed national reporting requirements.
Quality Innovation Network (QIN)-QIOs work with a variety of providers and care facilities to navigate quality reporting, the Physician Feedback/Value-Based Payment Modifier Program, and Quality and Resource Use Reports (QRURs).  Providers and facilities include:
  • Eligible physicians and physician groups
  • Inpatient and outpatient hospital departments
  • Acute care and critical access hospitals
  • Inpatient Psychiatric Facilities (IPFs)
  • PPS-exempt Cancer Hospitals (PCHs)
  • Ambulatory Surgical Centers (ASCs)

Quality Matters
As a health care provider, you’ve always done your best for patients. So why is it that hundreds of thousands of Americans die every year from medication errors, infections they acquired during a hospital stay, or other preventable consequences of seeking care?
It’s not because health care professionals are unskilled or uncaring. It’s because processes for delivering care have broken down, triggering adverse events and poor patient outcomes. Quality matters because lives are at stake. We are fully capable of doing better once processes associated with positive outcomes are in place.
Additionally, Quality matters because the economic landscape of health care is changing rapidly. Medicare has begun to pay dialysis centers and hospitals on the basis of quality, not solely volume. It has expanded its value-based purchasing programs into other care settings, including physician practices and ambulatory surgery centers. The providers most likely to succeed in the health care system of the future are those who can demonstrate clinical quality.
Let’s Improve Healthcare systems by:
Improving the Health Status of Communities
Promote Effective Prevention and Treatment of Chronic Disease by:
  • Provide more effective treatment to patients at risk for heart attack and stroke, especially those in underserved populations
  • Reduce disparities in diabetes care by supporting self-management education in disadvantaged communities
  • Use the electronic health records to their full potential, and to make sure patients receive preventive services

Promoting Safe Care that is Patient and Family-Centered, Reliable and Accessible
Reducing avoidable admissions and readmissions by improving the quality of care transitions. Their efforts resulted in approximately $1 billion in costs savings between 2011 and 2014, indicating an increase in the number days beneficiaries remain in their home.
Medication safety in all healthcare settings is essential to care coordination and the health of Medicare beneficiaries. Adverse drug events (ADEs) are a leading cause of preventable patient harm.  Poorly coordinated care can be a significant contributor to ADEs, particularly when multiple providers prescribe medications that could conflict and complicate the patient’s condition. ADEs cause unnecessary stress on the patient and the healthcare system and may contribute to:
  • Unnecessary diagnostic tests
  •   Avoidable hospital admissions/readmissions
  •   Preventable doctor’s office or ER visits
  •   Unneeded treatment
  •   Lost patient productivity
  •   Patient death

Make Care Safer and Reduce Harm Caused in the Delivery of Care by:
  • Working across the continuum of care to prevent healthcare-associated infections in hospitals and other care settings; providing assistance in spreading and sustaining evidence-based practices for infection prevention and reduction
  • Targeting prevention of healthcare-acquired conditions in nursing homes, and in all patient safety efforts, facilitating collaboration, innovation, and enhanced patient and family engagement

Promote Effective Communication and Coordination of Care by:
  • Helping community stakeholders, providers, patients, and families to organize for better coordination of care transitions, improved discharge communication, better access to community services and to share evidence-based approaches to reduce avoidable hospital readmissions, especially in vulnerable populations affected by poor care coordination
  • Working with providers and stakeholders across care settings to reduce potential adverse drug reactions, medication errors, overdoses, allergic reactions and other adverse drug events; promoting medication management strategies, especially for high-risk medications like anticoagulants, opioids, and diabetic agents

NOTE:
Between 2011 and 2014, QIO Program efforts to improve care transitions helped avoid approximately 44,640 potential ADEs.
Extracted from CMS QIO Program


Thursday, October 15, 2015

Differences between Chapter V (F) of ICD-10 and Chapter V of ICD-9 Mental and Behavioural Disorders

ICD-10 is larger than ICD-9. Numeric codes (001-999) were used in ICD-9, whereas an alphanumeric coding scheme, based on codes with a single letter followed by two numbers at the three-character level (A00-Z99), has been adopted in ICD-10. This has significantly enlarged the number of categories available for the classification. Further detail is then provided by means of decimal numeric subdivisions at the four-character level.

The chapter that dealt with mental disorders in ICD-9 had only 30 three-character categories (290-319); Chapter V (F) of ICD-10 has 100 such categories. A proportion of these categories have been left unused for the time being, so as to allow the introduction of changes into the classification without the need to redesign the entire system.

ICD-10 as a whole is designed to be a central ("core") classification for a family of disease and health related classifications. Some members of the family of classifications are derived by using a fifth or even sixth character to specify more detail. In others, the categories are condensed to give broad groups suitable for use, for instance, in primary health care or general medical practice. There is a multiaxial presentation of Chapter V (F) of ICD-10 and a version for child psychiatric practice and research. The "family" also includes classifications that cover information not contained in the ICD, but having important medical or health implications, e.g. the classification of impairments, disabilities and handicaps, the classification of procedures in medicine, and the classification of reasons for encounter between patients and health workers.

Definition Differences

Neurosis and psychosis

The traditional division between neurosis and psychosis that was evident in ICD-9
(although deliberately left without any attempt to define these concepts) has not been used in ICD-10. However, the term "neurotic" is still retained for occasional use and occurs, for instance, in the heading of a major group (or block) of disorders F40-F48, "Neurotic, stress-related and somatoform disorders". Except for depressive neurosis, most of the disorders regarded as neuroses by those who use the concept are to be found in this block, and the remainder are in the subsequent blocks. Instead of following the neurotic-psychotic dichotomy, the disorders are now arranged in groups according to major common themes or descriptive likenesses, which makes for increased convenience of use.

For instance, cyclothymia (F34.0) is in the block F30-F39, Mood [affective] disorders, rather than in F60-F69, Disorders of adult personality and behaviour; similarly, all disorders associated with the use of psychoactive substances are grouped together in F10-F19, regardless of their severity.

"Psychotic" has been retained as a convenient descriptive term, particularly in F23, Acute and transient psychotic disorders. Its use does not involve assumptions about psychodynamic mechanisms, but simply indicates the presence of hallucinations, delusions, or a limited number of severe abnormalities of behaviour, such as gross excitement and overactivity, marked psychomotor retardation, and catatonic behaviour.

All disorders attributable to an organic cause are grouped together in the block F00-F09, which makes the use of this part of the classification easier than the arrangement in the ICD-9.

The new arrangement of mental and behavioural disorders due to psychoactive substance use in the block F10-F19 has also been found more useful than the earlier system. The third character indicates the substance used, the fourth and fifth characters the psychopathological syndrome, e.g. from acute intoxication and residual states; this allows the reporting of all disorders related to a substance even when only three-character categories are used.

The block that covers schizophrenia, schizotypal states and delusional disorders (F20-F29) has been expanded by the introduction of new categories such as undifferentiated schizophrenia, postschizophrenic depression, and schizotypal disorder. The classification of acute short-lived psychoses, which are commonly seen in most developing countries, is considerably expanded compared with that in the ICD-9.

Classification of affective disorders has been particularly influenced by the adoption of the principle of grouping together disorders with a common theme. Terms such as "neurotic depression" and "endogenous depression" are not used, but their close equivalents can be found in the different types and severities of depression now specified (including dysthymia (F34.1)).

The behavioural syndromes and mental disorders associated with physiological dysfunction and hormonal changes, such as eating disorders, nonorganic sleep disorders, and sexual dysfunctions, have been brought together in F50-F59 and described in greater detail than in ICD-9, because of the growing needs for such a classification in liaison psychiatry.

Block F60-F69 contains a number of new disorders of adult behaviour such as pathological gambling, fire-setting, and stealing, as well as the more traditional disorders of personality.

Disorders of sexual preference are clearly differentiated from disorders of gender identity, and homosexuality in itself is no longer included as a category.

Differences on Disorders with onset specific to childhood

F80-F89 Disorders of psychological development Disorders of childhood such as infantile autism and disintegrative psychosis, classified in ICD-9 as psychoses, are now more appropriately contained in F84.-, pervasive developmental disorders. While some uncertainty remains about their nosological status, it has been considered that sufficient information is now available to justify the inclusion of the syndromes of Rett and Asperger in this group as specified disorders. Overactive disorder associated with mental retardation and stereotyped movements (F84.4) has been included in spite of its mixed nature, because evidence suggests that this may have considerable practical utility.

F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

Hyperkinetic disorder is now defined more broadly in ICD-10 than it was in ICD-9. The ICD-10 definition is also different in the relative emphasis given to the constituent symptoms of the overall hyperkinetic syndrome; since recent empirical research was used as the basis for the definition, there are good reasons for believing that the definition in ICD-10 represents a significant improvement.
Hyperkinetic conduct disorder (F90.1) is one of the few examples of a combination category remaining in ICD-10, Chapter V (F). The use of this diagnosis indicates that the criteria for both hyperkinetic disorder (F90.-) and conduct disorder (F91.-) are fulfilled.
These few exceptions to the general rule were considered justified on the grounds of clinical convenience in view of the frequent coexistence of those disorders and the demonstrated later importance of the mixed syndrome.

Oppositional defiant disorder (F91.3) was not in ICD-9, but has been included in ICD-10 because of evidence of its predictive potential for later conduct problems. There is, however, a cautionary note recommending its use mainly for younger children.

The ICD-9 category 313 (disturbances of emotion specific to childhood and adolescence) has been developed into two separate categories for ICD-10, namely emotional disorders with onset specific to childhood (F93.-) and disorders of social functioning with onset specific to childhood and adolescence (F94.-). This is because of the continuing need for a differentiation between children and adults with respect to various forms of morbid anxiety and related emotions. The frequency with which emotional disorders in childhood are followed by no significant similar disorder in adult life, and the frequent onset of neurotic disorders in adults are clear indicators of this need. The key defining criterion used in ICD-10 is the appropriateness to the developmental stage of the child of the emotion shown, plus an unusual degree of persistence with disturbance of function. In other words, these childhood disorders are significant exaggerations of emotional states and reactions that are regarded as normal for the age in question when occurring in only a mild form. If the content of the emotional state is unusual, or if it occurs at an unusual age, the general categories elsewhere in the classification should be used.

In spite of its name, the new category F94.- (disorders of social functioning with onset specific to childhood and adolescence) does not go against the general rule for ICD-10 of not using interference with social roles as a diagnostic criterion. The abnormalities of social functioning involved in F94.- are of a limited number and contained within the parent-child relationship and the immediate family; these relationships do not have the same connotations or show the same cultural variations as those formed in the context of work or of providing for the family, which are excluded from use as diagnostic criteria.

Users of blocks F80-F89 and F90-F98 also need to be aware of the contents of the neurological chapter of ICD-10 (Chapter VI (G)). This contains syndromes with predominantly physical manifestations and clear "organic" etiology, of which the Kleine-Levin syndrome (G47.8) is of particular interest to child psychiatrists.

Terminology differences

Disorder

The term "disorder" is used throughout the classification, so as to avoid even greater problems inherent in the use of terms such as "disease" and "illness". "Disorder" is not an exact term, but it is used here to imply the existence of a clinically recognizable set of symptoms or behaviour associated in most cases with distress and with interference with personal functions. Social deviance or conflict alone, without personal dysfunction, should not be included in mental disorder as defined here.

Psychogenic and psychosomatic

The term "psychogenic" has not been used in the titles of categories, in view of its different meanings in different languages and psychiatric traditions. It still occurs occasionally in the text, and should be taken to indicate that the diagnostician regards obvious life events or difficulties as playing an important role in the genesis of the disorder.

"Psychosomatic" is not used for similar reasons and also because use of this term might be taken to imply that psychological factors play no role in the occurrence, course and outcome of other diseases that are not so described.

Disorders described as psychosomatic in other classifications can be found in;

           F45.- somatoform disorders
           F50.- eating disorders
           F52.- sexual dysfunction
           F54.- psychologicalor behavioural factors associated with disorders or diseases classified                    elsewhere

It is particularly important to note category F54.- (category 316 in ICD-9) and to remember to use it for specifying the association of physical disorders, coded elsewhere in ICD-10, with an emotional causation.

A common example would be the recording of psychogenic asthma or eczema by means of    both F54 from Chapter V (F) and the appropriate code for the physical condition from other             chapters in ICD-10.


Dissociative and somatoform disorders, in relation to hysteria

The term "hysteria" has not been used in the title for any disorder in Chapter V (F) of ICD-10 because of its many and varied shades of meaning. Instead, "dissociative" has been preferred, to bring together disorders previously termed hysteria, of both dissociative and conversion types. This is largely because patients with the dissociative and conversion varieties often share a number of other characteristics, and in addition they frequently exhibit both varieties at the same or different times. It also seems reasonable to presume that the same (or very similar) psychological mechanisms are common to both types of symptoms.

Two categories that have been included here but were not present in ICD-9 are F68.0, elaboration of physical symptoms for psychological reasons, and F68.1, intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]. Since these are, strictly speaking, disorders of role or illness behaviour, it should be convenient for psychiatrists to have them grouped with other disorders of adult behaviour. Together with malingering (Z76.5), which has always been outside Chapter V of the ICD, the disorders from a trio of diagnoses often need to be considered together. The crucial difference between the first two and malingering is that the motivation for malingering is obvious and usually confined to situations where personal danger, criminal sentencing, or large sums of money are involved.

                                  Source World Health Organization (WHO)